Comparison of Individual Regimen Containing Bedaquiline with Delamanid and Bedaquiline without Delamanid on Efficacy and Safety in Multidrug-resistant Tuberculosis Patients: Implementation in Dr. Soetomo General Academic Hospital, Indonesia

Background: Bedaquiline is one of the core drugs used to treat multidrug-resistant TB (MDR-TB). Delamanid is one of the companion drugs in group C which is used to complete the treatment regimen when drugs in groups A and B can not be used. This study was conducted to analyze the efficacy and safety...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Soedarsono Soedarsono, Ni Made Mertaniasih, Tutik Kusmiati, Ariani Permatasari, Susi Subay, Suko Hari Adiono
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wolters Kluwer Medknow Publications 2024-06-01
Edice:	International Journal of Mycobacteriology
Témata:	acid-fast bacilli conversion bedaquiline delamanid individual regimen multidrug-resistant tuberculosis mycobacterium tuberculosis culture conversion qtc interval prolongation
On-line přístup:	https://journals.lww.com/10.4103/ijmy.ijmy_88_24
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!